siinfekl peptide Ovalbumin peptide SIINFEKL - OVApeptide Ovalbumin peptide SIINFEKL Unpacking the Significance of the SIINFEKL Peptide in Immunological Research

SIINFEKLTetramer The SIINFEKL peptide, a specific octameric sequence derived from chicken ovalbumin (OVA), holds a prominent position in the field of immunology. This ovalbumin-derived peptide SIINFEKL is not just another amino acid chain; it's a crucial tool for understanding and manipulating immune responses, particularly involving T cellsOvalbumin peptide SIINFEKL (H-2 Kb) for stimulation .... Its well-defined characteristics and predictable interactions with the immune system make it indispensable for a variety of research applications, from basic antigen processing studies to the development of novel vaccines and cancer therapies.

At its core, the SIINFEKL peptide is recognized as a class I (Kb)-restricted peptide epitope of OVA. This means it is presented by the MHC class I molecule, H-2Kb, on the surface of antigen-presenting cells. This presentation is critical for activating cytotoxic T lymphocytes (CTLs), specifically CD8+ T cells, which are key players in eliminating virus-infected cells and cancer cells. The sequence itself, SIINFEKL, is an eight-amino acid peptide that has been extensively studied and characterized. Its molecular formula is C45H74N10O13, with a molecular weight of approximately 963OVA G4 peptide TFA | SIINFEKL Cariant.1 g/mol....SIINFEKL. OVA 323-339: ISQAVHAAHAEINEAGR. Molecular weight. OVA 257-264: 963.2 g/mol / OVA 323-339: 1773.9 g/mol. Purity. ≥ 95% (UHPLC). Solubility. 1 mg/ml in ...

The utility of SIINFEKL stems from its role as an immunodominant epitope. This means it elicits a strong and consistent immune response, making it an ideal candidate for experimental manipulation. Researchers routinely use SIINFEKL to stimulate ovalbumin-specific T cells and to evaluate the efficacy of new vaccine adjuvants.MHC MACSimer H-2Kb Ovalbumin (SIINFEKL), mousehas been developed for the reliable detection, characterization, and isolation of antigen-specific T cells ... Its predictable interaction with the H-2Kb molecule allows for precise monitoring of antigen presentation and T cell activation. For instance, the 25-D1.16 monoclonal antibody is known to specifically react with the ovalbumin-derived peptide SIINFEKL bound to H-2Kb, providing a means to detect and quantify this specific peptide-MHC complex.

Beyond its direct use, variations of the SIINFEKL peptide are also of significant interestOVA (257-264) is a class I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb.. The OVA G4 peptide is a variant of the agonist ovalbumin (OVA) peptide SIINFEKL, offering researchers slightly altered properties for their studiesOvalbumin (257-264) chicken has been used to trigger T cell activation in immunology studies.Ova (257-264) - SIINFEKL gehört zu den T-Zell-Epitop-Peptiden.. These variants can be crucial for fine-tuning experimental outcomes or exploring the nuances of T cell receptor recognition.

The applications of SIINFEKL peptide are diverse and impactful.Biotinylated Mouse H-2Kb&B2M&OVA (SIINFEKL) ... In immunological studies, it serves as a standard model to investigate fundamental processes such as antigen processing and presentation. The SIINFEKL peptide is also instrumental in developing and testing anti-SIINFEKL antibodies, which can be used for various diagnostic and research purposes.Description, This is aclass I (Kb)-restricted peptide epitope of OVA, an octameric peptide from ovalbumin presented by the class I MHC molecule, H-2Kb. Furthermore, its role in T cell activation makes it relevant for cancer research and vaccine development.A SIINFEKL-Based System to Measure MHC Class I Antigen ... For example, SIINFEKL, a potent immunogenic peptide, plays a pivotal role in immunological studies, cancer research, and vaccine developmentOVA 257 264 peptide SIINFEKL - KLH conjugate. The ability to generate specific immune responses against tumor-associated antigens is a cornerstone of cancer immunotherapy, and SIINFEKL provides a well-understood model system for exploring such strategies.

The synthesis and availability of SIINFEKL peptide are crucial for its widespread use. Researchers can obtain this peptide in various forms, including as a single peptide (SIINFEKL) for direct stimulation of T cells, or conjugated to carrier proteins like KLH for antibody generation. The purity of these peptides is generally high, often ≥ 95% (UHPLC), ensuring reliable experimental resultsPeptideH-SIINFEKL^-OH is a ResearchPeptidewith significant interest within the field academic and medical research. Thispeptideis available for .... The OVA 257 264 peptide (SIINFEKL) is readily available from numerous scientific suppliers, often listed under catalog numbers like s7951 or EP01994_1.

Understanding the presentation of SIINFEKL is also key. It has been demonstrated that SIINFEKL is far more efficiently presented when DC are loaded directly with the SIINFEKL-peptide than when the peptide is cross-presented by H-2Kb molecules. This highlights the importance of the delivery method for optimal antigen presentation and subsequent immune activation. Tools like MHC MACSimer H-2Kb Ovalbumin (SIINFEKL), mouse have been developed for the reliable detection, characterization, and isolation of antigen-specific T cells, further underscoring the importance of this peptide in immunological research.

In summary, the SIINFEKL peptide is a foundational element in modern immunology.Ovalbumin (257-264) is a synthetic peptide fragmentcorresponding to the mouse MHC class I (H-2Kb) CD8+T cell-restricted epitope of chicken ovalbumin. It is ... Its precise amino acid sequence, its defined interaction with the H-2Kb MHC class I molecule, and its consistent ability to stimulate ovalbumin-specific CD8+ T cells make it an invaluable tool for researchPeptide-loaded dendritic cells prime and activate MHC- .... From elucidating fundamental immune mechanisms to driving the innovation of new therapeutic strategies, the SIINFEKL peptide continues to be a critical component in advancing our understanding of the immune system.